JPRN-UMIN000005616已完成未知
The usefulness of Cu-62 ATSM PET/CT to evaluate the sensitivity to radiotherapy for lung cancer and head and neck cancer - The evaluation of the sensitivity to radiotherapy by Cu-62 ATSM PET/CT
ational Cancer Center0 个研究点目标入组 47 人开始时间: 2011年5月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient under the psychological condition 2) Patient to whom imaging agents cannot be injected 3) Patient who was judged as unsuitable by the doctor
研究者
相似试验
已完成
不适用
Cu-62 ATSM PET/CT tests for thoracic an head and neck malignant tumorsthoracic malignalt tumors head and neck malignant tumorsJPRN-UMIN000016369ational Cancer Center5
已完成
不适用
Evaluation of 62Cu-ATSM PET/CT in carbon ion  radiotherapy to refractory cancerung cancer, Head and neck cancerJPRN-UMIN000005436ational Institute of Radiological Sciences100
招募中
2 期
Evaluation of 64Cu-ATSM PET/CT as a predictor of response to neoadjuvant therapy in locally advanced rectal cancer (TEP-64Cu-ATSM-Rectum)2024-512855-19-00Institut De Cancerologie De L Ouest70
进行中（未招募）
2 期
64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)Rectal CancerNCT03951337Institut Cancerologie de l'Ouest70
进行中（未招募）
1 期
Diagnostic-predictive value of copper-64 dichloride in bladder cancer patients eligible for chemotherapybladder cancer patients eligible for cisplatin chemotherapyMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-002534-37-ITENTE OSPEDALIERO OSPEDALI GALLIERA50